The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 50 results:
Author [ Title(Desc)] Type Year
Filters: Author is Lambrinoudaki, Irene  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
Paschou, S. A., Kosmopoulos M., Nikas I. P., Spartalis M., Kassi E., Goulis D. G., et al. (2019).  The Impact of Obesity on the Association between Vitamin D Deficiency and Cardiovascular Disease.. Nutrients. 11(10), 
Lambrinoudaki, I., Paschou S. A., Armeni E., & Goulis D. G. (2022).  The interplay between diabetes mellitus and menopause: clinical implications.. Nat Rev Endocrinol.
L
Anagnostis, P., Karras S., Lambrinoudaki I., Stevenson J. C., & Goulis D. G. (2016).  Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options.. Int J Clin Pract. 70(12), 967-977.
M
Stute, P., Spyropoulou A., Karageorgiou V., Cano A., Bitzer J., Ceausu I., et al. (2020).  Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement.. Maturitas. 131, 91-101.
Anagnostis, P., Vaitsi K., Veneti S., Georgiou T., Paschou S. A., Lambrinoudaki I., et al. (2019).  Management of dyslipidaemias in the elderly population-A narrative review.. Maturitas. 124, 93-99.
Russo, E., Caretto M., Giannini A., Bitzer J., Cano A., Ceausu I., et al. (2020).  Management of urinary incontinence in postmenopausal women: An EMAS clinical guide.. Maturitas.
Papastefanou, I., Eleftheriades M., Kappou D., Lambrinoudaki I., Lavranos D., Pervanidou P., et al. (2015).  Maternal serum osteocalcin at 11-14 weeks of gestation in gestational diabetes mellitus.. Eur J Clin Invest. 45(10), 1025-31.
Diamanti-Kandarakis, E., Dattilo M., Macut D., Duntas L., Gonos E. S., Goulis D. G., et al. (2017).  MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview.. Eur J Endocrinol. 176(6), R283-R308.
Cano, A., Marshall S., Zolfaroli I., Bitzer J., Ceausu I., Chedraui P., et al. (2020).  The Mediterranean diet and menopausal health: An EMAS position statement.. Maturitas. 139, 90-97.
Anagnostis, P., Paschou S. A., Katsiki N., Krikidis D., Lambrinoudaki I., & Goulis D. G. (2019).  Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?. Curr Vasc Pharmacol. 17(6), 564-572.
Goulis, D. G., & Lambrinoudaki I. (2015).  Menopausal hormone therapy for the prevention of cardiovascular disease: Evidence-based customization.. Maturitas. 81(4), 421-2.
Paschou, S. A., Goulis D. G., Lambrinoudaki I., & Papanas N. (2020).  Menopausal hormone therapy for women with obesity in the era of COVID-19.. Case Rep Womens Health. 27, e00233.
Polyzos, S. A., Lambrinoudaki I., & Goulis D. G. (2022).  Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease.. Hormones (Athens).
Karageorgiou, V., Lambrinoudaki I., & Goulis D. G. (2020).  Menopause in women with multiple sclerosis: A systematic review.. Maturitas. 135, 68-73.
Anagnostis, P., Bitzer J., Cano A., Ceausu I., Chedraui P., Durmusoglu F., et al. (2020).  Menopause symptom management in women with dyslipidemias: An EMAS clinical guide.. Maturitas. 135, 82-88.
Lambrinoudaki, I., Armeni E., Goulis D., Bretz S., Ceausu I., Durmusoglu F., et al. (2022).  Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society.. Maturitas. 163, 1-14.
Anagnostis, P., Lambrinoudaki I., Stevenson J. C., & Goulis D. G. (2022).  Menopause-associated risk of cardiovascular disease.. Endocr Connect. 11(4), 
N
Paschou, S. A., Polyzos S. A., Anagnostis P., Goulis D. G., Kanaka-Gantenbein C., Lambrinoudaki I., et al. (2019).  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.. Endocrine.
Mintziori, G., Goulis D. G., Lambrinoudaki I., Ceausu I., Depypere H., C Erel T., et al. (2015).  Non-hormonal management of menopausal vasomotor symptoms: Psychosocial interventions.. Maturitas. 82(4), 444-5.
O
Mili, N., Paschou S. A., Goulis D. G., Dimopoulos M-A., Lambrinoudaki I., & Psaltopoulou T. (2021).  Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations.. Endocrine. 74(3), 478-497.
S
Anagnostis, P., Dimopoulou C., Karras S., Lambrinoudaki I., & Goulis D. G. (2015).  Sarcopenia in post-menopausal women: Is there any role for vitamin D?. Maturitas. 82(1), 56-64.
T
Paschou, S. A., Marina L. V., Spartalis E., Anagnostis P., Alexandrou A., Goulis D. G., et al. (2019).  Therapeutic strategies for type 2 diabetes mellitus in women after menopause.. Maturitas. 126, 69-72.
Hirschberg, A. Lindén, Bitzer J., Cano A., Ceausu I., Chedraui P., Durmusoglu F., et al. (2021).  Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide.. Maturitas. 148, 55-61.
U
Nigdelis, M. P., Karamouzis M. V., Kontos M., Alexandrou A., Goulis D. G., & Lambrinoudaki I. (2021).  Updates on the treatment of invasive breast cancer: Quo Vadimus?. Maturitas. 145, 64-72.
Simoncini, T., Cano A., Goulis D. G., Lambrinoudaki I., Rees M., & Stute P. (2019).  On the use and abuse of register studies: The case of menopausal hormone therapy.. Maturitas. 123, 91-92.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.